ArriVent BioPharma, Inc. Common StockAVBPNASDAQ
Loading
Cash on hand plus short-term liquid investments
3Y CAGR
-34.7%/yr
Annual compound
Percentile
P25
Within normal range
vs 3Y Ago
0.3x
Contraction
Streak
3 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $45.54M | -38.7% |
| 2024 | $74.29M | -50.6% |
| 2023 | $150.39M | -7.9% |
| 2022 | $163.37M | +338.2% |
| 2021 | $37.28M | - |